开云app官网登录入口网页版-官方正版

#TNFi#

22篇内容 | 1341人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2224574, encodeId=004922245e450, content=<a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a> <a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a> <a href='/topic/show?id=d15b546e9f7' target=_blank style='color:#2F92EE;'>#托法替布#</a>, objectTitle=JCR：托法替布与TNF抑制剂在类风湿性关节炎患者中的安全性与有效性, objectType=article, longId=842173, objectId=64df8421e3e9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240906/1725637364274_5485250.png, objectUrl=/article/show_article.do?id=64df8421e3e9, replyNumber=0, likeNumber=23, createdTime=2024-09-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=64df8421e3e9, moduleTitle=JCR：托法替布与TNF抑制剂在类风湿性关节炎患者中的安全性与有效性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=64df8421e3e9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1624685, encodeId=fc4e162468528, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=ARD：IL-12/23通路抑制剂优特克单抗或TNFi 治疗银屑病关节炎患者的持久性和有效性相当, objectType=article, longId=730741, objectId=13a2e30741f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13a2e30741f5, replyNumber=0, likeNumber=71, createdTime=2022-06-30, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13a2e30741f5, moduleTitle=ARD：IL-12/23通路抑制剂优特克单抗或TNFi 治疗银屑病关节炎患者的持久性和有效性相当, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=13a2e30741f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624684, encodeId=823f162468420, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=J Rheumatol：银屑病关节炎中TNFi单药治疗与联合治疗的比较, objectType=article, longId=192087, objectId=6d0019208efd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d0019208efd, replyNumber=0, likeNumber=69, createdTime=2020-04-14, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d0019208efd, moduleTitle=J Rheumatol：银屑病关节炎中TNFi单药治疗与联合治疗的比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6d0019208efd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624683, encodeId=7ad61624683fa, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Ann Rheum Dis：TNFi初始治疗中轴型脊柱关节炎患者的治疗反应和药物保留率, objectType=article, longId=178121, objectId=60d91e8121fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60d91e8121fe, replyNumber=0, likeNumber=72, createdTime=2019-08-24, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60d91e8121fe, moduleTitle=Ann Rheum Dis：TNFi初始治疗中轴型脊柱关节炎患者的治疗反应和药物保留率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=60d91e8121fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624682, encodeId=ab631624682fb, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=J Rheumatol：银屑病关节炎患者使用TNFi达到缓解的预测因子, objectType=article, longId=158193, objectId=4a7b15819390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7b15819390, replyNumber=0, likeNumber=73, createdTime=2019-01-18, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7b15819390, moduleTitle=J Rheumatol：银屑病关节炎患者使用TNFi达到缓解的预测因子, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4a7b15819390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624681, encodeId=29e6162468105, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Ann Intern Med：TNFi治疗是否增加RA患者的癌症复发风险？, objectType=article, longId=151458, objectId=4e8615145865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e8615145865, replyNumber=0, likeNumber=59, createdTime=2018-10-22, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e8615145865, moduleTitle=Ann Intern Med：TNFi治疗是否增加RA患者的癌症复发风险？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4e8615145865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624680, encodeId=6d6b1624680b6, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Semin Arthritis Rheu：风湿病患者使用TNFi与周围神经病变风险, objectType=article, longId=150553, objectId=c1351505539c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1351505539c, replyNumber=0, likeNumber=57, createdTime=2018-10-09, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1351505539c, moduleTitle=Semin Arthritis Rheu：风湿病患者使用TNFi与周围神经病变风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c1351505539c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624679, encodeId=520316246e940, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Ann Rheum Dis：儿童使用TNFi增加恶性肿瘤风险？, objectType=article, longId=145820, objectId=117b145820e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=117b145820e5, replyNumber=0, likeNumber=67, createdTime=2018-08-05, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=117b145820e5, moduleTitle=Ann Rheum Dis：儿童使用TNFi增加恶性肿瘤风险？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=117b145820e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624678, encodeId=e37816246e85f, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=J Rheumatol：妊娠期暴露于TNFi的母亲和胎儿结局, objectType=article, longId=144431, objectId=c0a414443185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a414443185, replyNumber=0, likeNumber=61, createdTime=2018-07-16, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a414443185, moduleTitle=J Rheumatol：妊娠期暴露于TNFi的母亲和胎儿结局, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c0a414443185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624677, encodeId=d55716246e799, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Arthritis Rheumatol：TNFi vs.非甾体类抗炎药对早期强直性脊柱炎影像学进展的影响, objectType=article, longId=142987, objectId=721014298eee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=721014298eee, replyNumber=0, likeNumber=101, createdTime=2018-07-12, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=721014298eee, moduleTitle=Arthritis Rheumatol：TNFi vs.非甾体类抗炎药对早期强直性脊柱炎影像学进展的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=721014298eee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624676, encodeId=193316246e669, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素, objectType=article, longId=141443, objectId=c0ee14144387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0ee14144387, replyNumber=0, likeNumber=68, createdTime=2018-06-25, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0ee14144387, moduleTitle=J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c0ee14144387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624675, encodeId=411916246e5da, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=PLos One：多生物标志物疾病活动评分可作为类风湿性关节炎TNFi停药后复发的预测因子, objectType=article, longId=139062, objectId=178313906202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=178313906202, replyNumber=0, likeNumber=54, createdTime=2018-05-26, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=178313906202, moduleTitle=PLos One：多生物标志物疾病活动评分可作为类风湿性关节炎TNFi停药后复发的预测因子, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=178313906202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624674, encodeId=126616246e410, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=J Rheumatol：类风湿性关节炎开始阿巴西普或TNFi治疗后的心血管风险比较, objectType=article, longId=139026, objectId=14bf13902616, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14bf13902616, replyNumber=0, likeNumber=60, createdTime=2018-05-26, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14bf13902616, moduleTitle=J Rheumatol：类风湿性关节炎开始阿巴西普或TNFi治疗后的心血管风险比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=14bf13902616)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624673, encodeId=593216246e3a1, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Ann Rheum Dis：托珠单抗与TNFi单药或与常规DMARDs联合治疗类风湿性关节炎的疗效比较, objectType=article, longId=137675, objectId=d4a413e67570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4a413e67570, replyNumber=0, likeNumber=60, createdTime=2018-05-11, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4a413e67570, moduleTitle=Ann Rheum Dis：托珠单抗与TNFi单药或与常规DMARDs联合治疗类风湿性关节炎的疗效比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d4a413e67570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624672, encodeId=a11e16246e22a, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=J Rheumatol ：脊柱关节炎10年TNFi药物生存率的预测因子, objectType=article, longId=134101, objectId=171013410101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=171013410101, replyNumber=0, likeNumber=79, createdTime=2018-04-04, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=171013410101, moduleTitle=J Rheumatol ：脊柱关节炎10年TNFi药物生存率的预测因子, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=171013410101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624671, encodeId=8d3916246e1a6, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Ann Rheum Dis：患者特征影响RA生物性药物的选择，并使非TNFi生物制剂显得比TNFi生物制剂更有害, objectType=article, longId=123567, objectId=bac512356e55, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bac512356e55, replyNumber=0, likeNumber=72, createdTime=2017-12-17, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bac512356e55, moduleTitle=Ann Rheum Dis：患者特征影响RA生物性药物的选择，并使非TNFi生物制剂显得比TNFi生物制剂更有害, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bac512356e55)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624670, encodeId=ab7116246e0ac, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Rheumatology (Oxford)：RA优化治疗：TNFi剂量递减是否疗效好？, objectType=article, longId=120561, objectId=5ffd120561e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ffd120561e7, replyNumber=0, likeNumber=70, createdTime=2017-11-19, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ffd120561e7, moduleTitle=Rheumatology (Oxford)：RA优化治疗：TNFi剂量递减是否疗效好？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5ffd120561e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624669, encodeId=bc6516246692c, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Ann Rheum Dis： MTX单药与TNFi（阿达木单抗）联合MTX治疗早期类风湿关节炎的治疗靶向结局比较, objectType=article, longId=120545, objectId=777012054511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=777012054511, replyNumber=0, likeNumber=83, createdTime=2017-11-19, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=777012054511, moduleTitle=Ann Rheum Dis： MTX单药与TNFi（阿达木单抗）联合MTX治疗早期类风湿关节炎的治疗靶向结局比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=777012054511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624668, encodeId=9eb41624668ae, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=NSAIDs和TNFi治疗可协同延缓AS的进展, objectType=article, longId=82447, objectId=ce8e8244e14, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce8e8244e14, replyNumber=0, likeNumber=87, createdTime=2016-11-17, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce8e8244e14, moduleTitle=NSAIDs和TNFi治疗可协同延缓AS的进展, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ce8e8244e14)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1624667, encodeId=3150162466e71, content=<a href='/topic/show?id=c4531e588ea' target=_blank style='color:#2F92EE;'>#TNFi#</a>, objectTitle=Arthritis Rheum：RA患者暴露于TNFi，不会增加缺血性卒中风险, objectType=article, longId=72722, objectId=1ff4e272219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff4e272219, replyNumber=0, likeNumber=72, createdTime=2016-07-14, rootId=0, userName=xiongliangxl, userId=236b20684967, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff4e272219, moduleTitle=Arthritis Rheum：RA患者暴露于TNFi，不会增加缺血性卒中风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1ff4e272219)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

TNFi

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#类风湿性关节炎# #TNFi# #托法替布#

JCR：托法替布与TNF抑制剂在类风湿性关节炎患者中的安全性与有效性

2024-09-07发表于上海

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

ARD：IL-12/23通路抑制剂优特克单抗或TNFi 治疗银屑病关节炎患者的持久性和有效性相当

2022-06-30

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

J Rheumatol：银屑病关节炎中TNFi单药治疗与联合治疗的比较

2020-04-14

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Ann Rheum Dis：TNFi初始治疗中轴型脊柱关节炎患者的治疗反应和药物保留率

2019-08-24

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

J Rheumatol：银屑病关节炎患者使用TNFi达到缓解的预测因子

2019-01-18

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Ann Intern Med：TNFi治疗是否增加RA患者的癌症复发风险？

2018-10-22

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Semin Arthritis Rheu：风湿病患者使用TNFi与周围神经病变风险

2018-10-09

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Ann Rheum Dis：儿童使用TNFi增加恶性肿瘤风险？

2018-08-05

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

J Rheumatol：妊娠期暴露于TNFi的母亲和胎儿结局

2018-07-16

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Arthritis Rheumatol：TNFi vs.非甾体类抗炎药对早期强直性脊柱炎影像学进展的影响

2018-07-12

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

J Rheumatol：脊柱关节炎患者10年TNFi药物生存率的比较分析及预测因素

2018-06-25

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

PLos One：多生物标志物疾病活动评分可作为类风湿性关节炎TNFi停药后复发的预测因子

2018-05-26

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

J Rheumatol：类风湿性关节炎开始阿巴西普或TNFi治疗后的心血管风险比较

2018-05-26

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Ann Rheum Dis：托珠单抗与TNFi单药或与常规DMARDs联合治疗类风湿性关节炎的疗效比较

2018-05-11

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

J Rheumatol ：脊柱关节炎10年TNFi药物生存率的预测因子

2018-04-04

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Ann Rheum Dis：患者特征影响RA生物性药物的选择，并使非TNFi生物制剂显得比TNFi生物制剂更有害

2017-12-17

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Rheumatology (Oxford)：RA优化治疗：TNFi剂量递减是否疗效好？

2017-11-19

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Ann Rheum Dis： MTX单药与TNFi（阿达木单抗）联合MTX治疗早期类风湿关节炎的治疗靶向结局比较

2017-11-19

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

NSAIDs和TNFi治疗可协同延缓AS的进展

2016-11-17

xiongliangxl (审核中...)

前往app查看评论内容

#TNFi#

Arthritis Rheum：RA患者暴露于TNFi，不会增加缺血性卒中风险

2016-07-14

科室
- - 订阅+
  - 更多科室
工具
服务